Clinical Trial Update: Evaluation of CMV/EBV-CMI in Haploid HSCT

View source ↗

Summary

A study evaluating CMV/EBV-specific cellular immune responses in haploid hematopoietic stem cell transplantation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Epstein-barr Virus Infection

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections | Status: RECRUITING